Stay updated on Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the Record History and Revision: v3.4.2 was removed, updating the list of version changes for the study record.
    Difference
    0.1%
    Check dated 2026-03-10T02:40:26.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the Study Record Versions and the previous revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-16T16:28:32.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now listed. The previous government funding operating-status notice associated with v3.4.0 has been removed.
    Difference
    0.8%
    Check dated 2026-02-09T13:29:02.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The update adds a glossary display and color-coded highlights for additions and deletions, plus a new revision label (v3.4.0). These are UI/formatting changes and do not affect the study data.
    Difference
    1%
    Check dated 2026-01-26T10:23:29.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The Record History page shows a new revision entry (v3.3.4) and the previous revision (v3.3.3) has been removed, reflecting a minor update to the page's version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-19T07:44:04.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Added a new Revision: v3.3.3 and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. These changes are cosmetic and do not alter study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-21T21:21:13.000Z thumbnail image

Stay in the know with updates to Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.